neutral endopeptidase inhibitors (e.g., thiorphan and phosphoramidon), al angiotensin converting enzyme inhibitors e sildenafil, tadalfil and vardenafil vasodilators calcium channel blockers e.g., amlodipine, nifedipine, verastrial, diltiazem, gallopamil, niludipine, nimodipins, nicardipine potassium channel activators e.g., nicorandil, pinacidil, cromakalim, minoxidil, aprilkalim, loprazolam diuretics e.g., hydrochlorothiazide sympatholitics e.g., beta-adrenergic blocking drugs (e.g., propranolol, atenolol, bisoprolol, carvedilol, metoprolol, or metoprolol tartate), alpha adrenergic blocking drugs (e.g., doxazosin, prazosin or alpha methyldo lipid lowering agents e.g., HMG-CoA reductase inhibitors such as simvastatin and lovastatin which are marketed as ZOCOR and MEVACOR in lactone pro-drug form and function as inhibitors after administration, and pharmaceutically acceptable salts of dihydroxy open ring acid HMG-CoA reductase inhibitors such as atorvastatin (particularly the calcium salt sold in LIPITOR@), rosuvastatin (particularly the calcium salt sold in CRESTOR), pravastatin (particularly the sodium salt sold in PRAVACHOL), fluvastatin (particularly the sodium salt sold in LESCOL), cerivastatin, and pitavastatin
Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery
Gut microbiota play a crucial role in maintaining the intestinal barrier [11]
NAC, which serves as a potential anti-ferroptosis agent, is expected to contribute significantly to the treatment of endometriosis
